Authorized purpose: Constellation is intended for non-invasive labeling and calculation of quantitative measurements for anatomical regions using whole-body DICOM MR images gathered on a GE MR450W. It is intended for healthy adult patients and may be used as a clinical decision-support tool, but not in triage events, emergency medicine, or critical care; a clinician retains responsibility for diagnosis.
Clinical role
MRI acquisition, reconstruction, display, and release-specific image processing under professional review.
Images and patients
MRI · Whole body including lower-limb muscles, visceral and subcutaneous adipose tissue, kidneys, liver, spleen, lungs, and brain structures
Key limitation
Keep in mind: The exact indication is limited to healthy adults and excludes triage, emergency medicine, and critical care; Constellation is not intended as the sole source of diagnosis.
Clinical detailsPurpose, workflow fit, evidence, and safety record
Workflow navigation pilot
Workflow role has not yet been reviewed for this navigation pilot.
A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources
What does this software do?Authorized purpose: Constellation is intended for non-invasive labeling and calculation of quantitative measurements for anatomical regions using whole-body DICOM MR images gathered on a GE MR450W. It is intended for healthy adult patients and may be used as a clinical decision-support tool, but not in triage events, emergency medicine, or critical care; a clinician retains responsibility for diagnosis.
Which images or clinical context are in scope?Modality: MRI Anatomy or clinical context: Whole body including lower-limb muscles, visceral and subcutaneous adipose tissue, kidneys, liver, spleen, lungs, and brain structures Input: MRI signal data acquired with the supported field strength, coils, sequences, contrast, and patient configuration.
Who uses it?Intended users: Trained physicians and MRI professionals qualified for the labeled system and applications.
What does the software produce?Output: Cross-sectional MR images, spectra, parametric maps, dynamic images, and derived views for professional review.
What is its most important limitation?Key limitation: The exact indication is limited to healthy adults and excludes triage, emergency medicine, and critical care; Constellation is not intended as the sole source of diagnosis.
Clinical takeaway. Clinical role: Constellation is intended for non-invasive labeling and calculation of quantitative measurements for anatomical regions using whole-body DICOM MR images gathered on a GE MR450W. It is intended for healthy adult patients and may be used as a clinical decision-support tool, but not in triage events, emergency medicine, or critical care; a clinician retains responsibility for diagnosis.
Evidence takeaway. Evidence from the reviewed source record: The exact FDA document reports clinical and non-clinical tests: segmentation accuracy for lungs, liver, spleen, kidneys, muscle and fat (Dice Similarity Coefficient, mean percent absolute difference) and for brain cortical/subcortical regions; liver VOI placement by majority voting of three radiologists; device and test-retest repeatability; and inter- and intra-rater studies establishing manual ground truth. Software verification and usability testing showed passing results. Results are as reported in the FDA submission, not independent validation.
Evidence context
Evidence context not reviewed for this FDA record.
Public-label constraints
Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.
Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.
Purpose
Constellation is intended for non-invasive labeling and calculation of quantitative measurements for anatomical regions using whole-body DICOM MR images gathered on a GE MR450W. It is intended for healthy adult patients and may be used as a clinical decision-support tool, but not in triage events, emergency medicine, or critical care; a clinician retains responsibility for diagnosis.
The exact indication is limited to healthy adults and excludes triage, emergency medicine, and critical care; Constellation is not intended as the sole source of diagnosis.
The exact FDA document reports clinical and non-clinical tests: segmentation accuracy for lungs, liver, spleen, kidneys, muscle and fat (Dice Similarity Coefficient, mean percent absolute difference) and for brain cortical/subcortical regions; liver VOI placement by majority voting of three radiologists; device and test-retest repeatability; and inter- and intra-rater studies establishing manual ground truth. Software verification and usability testing showed passing results. Results are as reported in the FDA submission, not independent validation.
Exact FDA submission
Checked 2026-11-14
Packet wording: "The following clinical and non-clinical tests were performed to evaluate" … "Segmentation accuracy of the lungs, liver, spleen, kidneys, muscle, and fat (visceral and subcutaneous) is evaluated using the Dice Similarity Coefficient (DSC) and mean percent absolute difference as primary and secondary figures of merit (FOM). ● Segmentation accuracy for brain cortical/subcortical regions is evaluated via". Read from the exact FDA decision document on 2026-11-14.
Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.
Evidence summary
The exact FDA document reports clinical and non-clinical tests: segmentation accuracy for lungs, liver, spleen, kidneys, muscle and fat (Dice Similarity Coefficient, mean percent absolute difference) and for brain cortical/subcortical regions; liver VOI placement by majority voting of three radiologists; device and test-retest repeatability; and inter- and intra-rater studies establishing manual ground truth. Software verification and usability testing showed passing results. Results are as reported in the FDA submission, not independent validation.
FDA source
Exact FDA submission
Checked 2026-11-14
Packet wording: "The following clinical and non-clinical tests were performed to evaluate" … "Segmentation accuracy of the lungs, liver, spleen, kidneys, muscle, and fat (visceral and subcutaneous) is evaluated using the Dice Similarity Coefficient (DSC) and mean percent absolute difference as primary and secondary figures of merit (FOM). ● Segmentation accuracy for brain cortical/subcortical regions is evaluated via". Read from the exact FDA decision document on 2026-11-14.
Sensitivity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, study design, and source if separately verified.
Reported specificity
Not applicable
Not applicable
Not applicable
Checked 2026-09-04
Specificity is not promoted as a product-wide endpoint. Compare only an exact endpoint, threshold, population, version, study design, and source if separately verified.
No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.
K241280 FDA decision evidence package for Constellation (CON-001)
DesignFDA decision evidence and product verification described in the exact submission or PMA decision record.
PopulationWhole body including lower-limb muscles, visceral and subcutaneous adipose tissue, kidneys, liver, spleen, lungs, and brain structures
Scopeexact submission
Tested versionConstellation (CON-001) configuration described in K241280
IndependenceSponsor or vendor study
K241280
FDA decision material is manufacturer-submitted regulatory evidence. It is not independent clinical validation unless the exact source expressly establishes that distinction; local technical, clinical, privacy, security, and workflow acceptance remains necessary.
Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.
Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K241280 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
Public source
Exact FDA submission
Checked 2026-09-04
Exact-identifier review does not prove absence of all product-family safety signals.
IT implementationDeployment, interfaces, data handling, and support
System and version relationships
Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.
No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.
Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.
Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner
No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.
Acquisition/source
Source context, not route validation: MRI signal data acquired with the supported field strength, coils, sequences, contrast, and patient configuration.
Scope: Exact FDA submission.
Confirm scanner/model, protocol, series completeness and both software builds.
Source context, not route validation: The exact FDA package describes whole-body DICOM MR input from a GE MR450W and quantified labels, measurements, whole-body visualization, and PDF reporting; verify the installed scanner, study identity, routing, report, and archive behavior.
Scope: Exact FDA submission. This is a partial interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.
Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.
Source context, not route validation: The exact FDA package describes internal-server hosting on off-the-shelf hardware; current infrastructure, contracts, security, availability, and site configuration remain unknown.
Scope: Exact FDA submission. This is a partial release-level topology fact from the exact FDA package; current hosting, contracts, security, availability, and site configuration remain separate evidence.
Confirm processing location, queue ownership, exclusions and exact AI build.
Unresolved route: Cross-sectional MR images, spectra, parametric maps, dynamic images, and derived views for professional review.
Scope: Exact FDA submission.
Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.
Unresolved route: Not established for the exact route.
Scope: Scope not established.
Name the local, platform and AI supplier support owners and escalation path.
Planned local route tests
No tests below have been performed or accepted.
Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.
Local implementation checklist
Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.
The exact FDA package describes internal-server hosting on off-the-shelf hardware; current infrastructure, contracts, security, availability, and site configuration remain unknown.
Exact FDA submission
Checked 2026-09-04
This is a partial release-level topology fact from the exact FDA package; current hosting, contracts, security, availability, and site configuration remain separate evidence.
The exact FDA package describes whole-body DICOM MR input from a GE MR450W and quantified labels, measurements, whole-body visualization, and PDF reporting; verify the installed scanner, study identity, routing, report, and archive behavior.
Exact FDA submission
Checked 2026-09-04
This is a partial interface boundary described in the exact FDA package; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.
Only trained physicians and mri professionals qualified for the labeled system and applications should operate or interpret the product. Local onboarding should cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
Monitor K241280 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The exact indication is limited to healthy adults and excludes triage, emergency medicine, and critical care; Constellation is not intended as the sole source of diagnosis.
Exact FDA submission
Checked 2026-09-04
This is buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.
The exact FDA package describes internal-server hosting on off-the-shelf hardware; current infrastructure, contracts, security, availability, and site configuration remain unknown.
exact submission · checked 2026-09-04
FDA-described topology does not establish current hosting contracts, security controls, uptime, or local qualification.
The exact FDA package describes whole-body DICOM MR input from a GE MR450W and quantified labels, measurements, whole-body visualization, and PDF reporting; verify the installed scanner, study identity, routing, report, and archive behavior.
exact submission · checked 2026-09-04
Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.
Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. The exact indication is limited to healthy adults and excludes triage, emergency medicine, and critical care; Constellation is not intended as the sole source of diagnosis.
exact submission · checked 2026-09-04
Define stop-use, escalation, rollback, and revalidation triggers before production use.
Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.
exact submission · checked 2026-09-04
No exact-product price or reimbursement determination was promoted.
Monitor K241280 by exact hardware, software, model, and algorithm version; patient population; anatomy; protocol; operator; input quality; output edits or overrides; failed studies; repeat acquisition or rework; downstream impact; downtime; incidents; recalls; and updates. Track these product-specific limits: The exact indication is limited to healthy adults and excludes triage, emergency medicine, and critical care; Constellation is not intended as the sole source of diagnosis.
exact submission · checked 2026-09-04
Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.
Sources & review detailsFDA identity, research record, source ledger, and history
Regulatory identity
FDA record and catalog context
The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.
This audit distinguishes completed source review from fields that have not yet been researched.
Exact FDA record reviewedStatus
2026-09-20Last searched
27Fields reviewed
10Source classes checked
20Screened PubMed leads
10Screened trial leads
0Unreviewed FDA recall leads
The refreshed discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records. Discovery metadata alone does not establish exact tested-product, version, population, and endpoint applicability, so all candidates remain quarantined and none was promoted. The current discovery snapshot contains 20 PubMed and 10 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.
Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.
Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, fda device recall, literature index, trial registry, pubmed, clinical trials, openfda device recall
Field review details
Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.
Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission
No public list price for the exact cleared or authorized configuration was found. Obtain a written quote separating license or hardware basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.
Pricing model: Not yet reviewed
Setup and integration fees: Not yet reviewed
Recurring fees: Not yet reviewed
Minimum commitment: Not yet reviewed
Contract duration: Not yet reviewed
Renewal terms: Not yet reviewed
Cancellation terms: Not yet reviewed
Support and service terms: Not yet reviewed
Trial or pilot terms: Not yet reviewed
Reimbursement: Not publicly available - checked 2026-09-04 - Exact FDA submission
No exact-product reimbursement determination was promoted in this timeboxed review. Verify payer, site-of-service, coding, coverage, and local payment assumptions independently.
Data hosting location: Not yet reviewed
Data retention: Not yet reviewed
Documented data use: Not yet reviewed
Hardware requirements: Not yet reviewed
Network requirements: Not yet reviewed
Identity and access: Not yet reviewed
Security: Not publicly available - checked 2026-09-04 - Exact FDA submission
Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.
Authorized purpose: LiverMultiScan v6.0 is MR diagnostic software for non-invasive liver-health assessment that generates, displays, and supports review of MR data and quantitative cT1, PDFF, and LIC metrics or composite images for trained healthcare-professional interpretation.
Authorized purpose: TumorSight Viz processes dynamic contrast-enhanced breast MRI for patients with biopsy-proven early-stage or locally advanced breast cancer, providing registration, subtraction, segmentation, 3D renderings, measurements, kinetic curves, parametric maps, MIPs, and reformats for physician visualization and analysis; results are not the sole basis for patient management.
Authorized purpose: Prenuvo Body Composition is software that non-invasively quantifies fat, muscle, and organs from compatible MR DICOM datasets and displays internal body information, including liver and body-composition measurements, for adults age 18 and older.
Modality
MRI
Anatomy
Whole-body anatomy, liver, organs, fat, and muscle
Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.
Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.
Accepted repository change history
No entry has been added to this scoped change history for this record. This is not proof that the record never changed.